scispace - formally typeset
Book ChapterDOI

Chloroquine in the Treatment of Porphyria Cutanea Tarda

V Kordac, +2 more
- 01 Jan 1978 - 
- Vol. 296, Iss: 16, pp 127-132
Reads0
Chats0
TLDR
The indisputable etiologic role of alcohol consumption as well as to the influence of gradual chemical pollution of the environment are pointed to.
Abstract
The frequency of porphyria cutanea tarda (PCT) has been increasing greatly and its incidence at present in our country can be estimated to one case in 2000–5000 inhabitants. A striking fact is an apparent shift in the incidence of the disease to younger age groups. Analysis of causes of the increasing frequency of PCT lies beyond the scope of this paper. Nevertheless, we would like to point to the indisputable etiologic role of alcohol consumption as well as to the influence of gradual chemical pollution of the environment. In porphyric patients signs of liver injury can be found frequently, with the degree of liver damage directly proportional to the duration of the disease and to the age of patient. Besides liver cirrhosis and a frequent incidence of hepatoma in cirrhosis in later stages of the disease occurring 100–200 times more often in untreated patients than in normal population, signs of chronic hepatitis confirmed both in biochemical tests and in histologic pictures of liver biopsies can be found most frequently.

read more

Citations
More filters
Journal ArticleDOI

Porphyria cutanea tarda--when skin meets liver.

TL;DR: The diagnosis of PCT can be made based on the skin symptoms, a characteristic urinary porphyrin excretion profile, and the detection of isocoproporphyrIn in the feces.
Journal ArticleDOI

Low-Dose Hydroxychloroquine Is as Effective as Phlebotomy in Treatment of Patients With Porphyria Cutanea Tarda

TL;DR: Hydxychloroquine, 100 mg orally, twice weekly, is as effective and safe as phlebotomy in patients with PCT, although noninferiority was not established.
Journal ArticleDOI

Porphyria cutanea tarda: Recent update.

TL;DR: Ret retrospective and observational studies shows the relapse rate to be somewhat higher after remission with low-dose hydroxychloroquine as compared to phlebotomy induced remission, and future studies are needed on exploring mechanism of action of 4-aminoquinolines, understanding interaction of HCV and PCT, and relapse of PCT on long-term follow-up.
Journal ArticleDOI

Hydroxychloroquine Treatment of Porphyria Cutanea Tarda

TL;DR: Six patients with skin changes and urinary porphyrin excretion patterns characteristic for porphyria cutanea tarda were treated with hydroxychloroquine sulfate therapy, and during treatment periods ranging from five to 13 months, cutaneous symptoms disappeared and urinary PPH excretion abnormalities were completely or almost completely reversed.
References
More filters
Journal ArticleDOI

The Molecular Basis of the Action of Chloroquine in Porphyria Cutanea Tarda

TL;DR: In vitro studies suggest that the initial event following chloroquine administration to patients with PCT is a release of bound hepatic porphyrin and its rapid elimination, and equilibrium dialysis studies demonstrate that chlorquine causes the release of tissue-bound prophyrins.
Journal ArticleDOI

Porphyria Cutanea Tarda: Remission Following Chloroquine Administration Without Adverse Effects

TL;DR: A case of porphyria cutanea tarda is presented in which clinical and biochemical remission were associated with the administration of 0.5 gm of chloroquine twice weekly over a seven-month period without adverse effects.
Related Papers (5)